| Breakdown | Jan 2026 | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.90B | 6.12B | 5.49B | 5.03B | 4.63B |
| Gross Profit | 3.05B | 2.64B | 2.42B | 2.21B | 1.98B |
| EBITDA | 1.28B | 1.39B | 1.35B | 1.17B | 1.13B |
| Net Income | 888.50M | 736.10M | 802.30M | 711.70M | 677.50M |
Balance Sheet | |||||
| Total Assets | 4.92B | 4.87B | 4.72B | 3.98B | 3.98B |
| Cash, Cash Equivalents and Short-Term Investments | 102.60M | 200.40M | 188.30M | 105.00M | 468.50M |
| Total Debt | 1.21B | 1.87B | 1.92B | 1.92B | 2.11B |
| Total Liabilities | 3.13B | 3.12B | 3.09B | 2.82B | 2.97B |
| Stockholders Equity | 1.66B | 1.64B | 1.51B | 1.16B | 1.01B |
Cash Flow | |||||
| Free Cash Flow | 1.00B | 976.40M | 932.10M | 494.30M | 626.70M |
| Operating Cash Flow | 1.14B | 1.13B | 1.12B | 740.40M | 893.00M |
| Investing Cash Flow | -119.90M | -181.20M | -334.40M | -271.40M | -292.50M |
| Financing Cash Flow | -1.13B | -939.60M | -663.30M | -727.10M | -993.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.75B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
70 Outperform | £14.38B | 17.45 | 51.86% | 1.80% | 9.74% | 0.92% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £6.70B | 298.74 | 0.69% | 1.18% | 14.13% | -96.12% | |
55 Neutral | £3.70B | -40.23 | -2.99% | ― | -9.44% | -170.53% | |
52 Neutral | £277.70M | -1.12 | -111.93% | ― | -14.89% | 12.08% | |
41 Neutral | £265.71M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |